Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 103-110.doi: 10.6040/j.issn.1671-7554.0.2020.1656

Previous Articles     Next Articles

Silencing PRRX1 gene expression enhances the sensitivity of prostate cancer resistant cell line PC-3/DTX to docetaxel

XU Bing1, LI Yong2, LIU Ming1, LIU Yonghui1   

  1. 1. Department of Urology, The Third Affiliated Hospital of Nanhua University, Hengyang 421900, Hunan, China;
    2. Department of Urology, The Second Affiliated Hospital of Nanhua University, Hengyang 421900, Hunan, China
  • Published:2021-06-10

PDF (PC)

517

Abstract: Objective To explore the effects of paired-related homeobox 1(PRRX1)gene silencing on the sensitivity of drug-resistant prostate cancer cells to docetaxel(DTX)and the possible mechanism. Methods The cancer tissues of 35 patients who were DTX chemotherapy sensitive(DTX-S)and 29 patients who were DTX chemotherapy resistant(DTX-R)were collected. The mRNA expression of PRRX1 in cancer tissues was detected with qRT-PCR. Human prostate cancer PC-3 cells were cultured in vitro, and the DTX-resistant cell line PC-3/DTX was established by increasing DTX concentration intermittently. The mRNA and protein expressions of PRRX1 in the drug-resistant PC-3/DTX and the parental PC3 cells were detected with qRT-PCR and Western blotting. The expression of PRRX1 gene in PC-3/DTX cells was silenced by siRNA, and the mRNA and protein expressions of PRRX1 in PC-3/DTX cells after transfection were detected with qRT-PCR and Western blotting. After DTX intervention, PC-3/DTX cells were transfected for 24 hours. The cell proliferation was detected with MTT, and the half inhibitory concentration(IC50)and drug resistance index(RI)were calculated. The cell apoptosis was detected with flow cytometry. The protein expressions of cleaved caspase-3, p-mTOR, mTOR, Beclin-1 and LC-3 were detected with Western blotting. Results The mRNA expression of PRRX1 in DTX-R cancer was higher than that in DTX-S cancer(6.59±1.49 vs 1.07±0.34)(F=656.401, P<0.05). The IC50 values of the drug-resistant cell line PC-3/DTX and the parental PC-3 cells treated with different concentrations of DTX for 24 h were(89.88±6.86)nmol/L and(15.56±1.45)nmol/L, respectively, and the RI was 5.78. The mRNA and protein expressions of PRRX1 in the drug-resistant cell line PC-3/DTX were higher than those in the parental PC-3 cells(mRNA: 9.22±1.50 vs 1.00±0.17; protein: 0.50±0.04 vs 0.08±0.02)(FmRNA=59.05, Fprotein=171.70, P<0.05). After the PRRX1 gene was silenced, the mRNA and protein expressions of PRRX1 in PC-3/DTX cells reduced(mRNA: 1.01±0.02 vs 0.98±0.04 vs 0.22±0.10; protein: 0.62±0.01 vs 0.61±0.01 vs 0.11±0.01)(FmRNA=122.01, Fprotein=554.53, P<0.05). Silencing the PRRX1 gene reduced the resistance of PC-3/DTX cells to DTX, promoted cell apoptosis, and up-regulated the expressions of p-mTOR and cleaved caspase-3, and down-regulated the protein expressions of Beclin-1 and LC-3(P<0.05). Conclusion Silencing the expression of the PRRX1 gene can enhance the sensitivity of the prostate cancer drug-resistant cell line PC-3/DTX to DTX, and the mechanism may be related to the activation of the mTOR signaling pathway to inhibit autophagy.

Key words: Gene silencing, Paired related homeobox 1, Prostate cancer, Docetaxel, Drug resistance, Autophagy

CLC Number: 

  • R737.1
[1] Zhu Y, Freedland SJ, Ye D. Prostate cancer and prostatic diseases best of Asia, 2019: challenges and opportunities [J]. Prostate Cancer Prostatic Dis, 2020, 23(2): 197-198.
[2] Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells [J]. Cancer Cell, 2012, 22(3): 373- 388.
[3] 李宁宁, 郭振英. PRRX1 在 EMT 及维持肿瘤干性中的研究进展[J]. 临床与实验病理学杂志, 2018, 34(4): 83-85. LI Ningning, GUO Zhenying. Research progress of PRRX1 in EMT and maintenance of tumor dryness [J]. Chinese Journal of Clinical and Experimental Pathology, 2018, 34(4): 83-85.
[4] Dong J, Lv Z, Chen Q, et al. PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells [J]. Int J Clin Exp Pathol, 2018, 11(5): 2629-2635.
[5] Wang S, Ping M, Song B, et al. Exosomal circ PRRX1 enhances doxorubicin resistance in gastric cancer by regulating miR-3064-5p/PTPN14 signaling [J]. Yonsei Med J, 2020, 61(9): 750-761.
[6] 朱小长, 陶连元, 杜瀛瀛, 等. mTOR抑制剂通过mTOR通路介导胰腺癌顺铂耐药的机制研究[J]. 安徽医科大学学报, 2019, 54(8): 1205-1210. ZHU Xiaozhang, TAO Lianyuan, DU Yingying, et al. Mechanism of mTOR inhibitors in cisplatin resistance in pancreatic cancer by mediating the mTOR pathway [J]. Acta Universitatis Medicinalis Anhui, 2019, 54(8): 1205-1210.
[7] Gremke N, Polo P, Dort A, et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability [J]. Nat Commun, 2020, 11(1): 4684.
[8] 马琪, 李永红, 杨斌, 等. 前列腺癌化疗安全共识[J]. 现代泌尿外科杂志, 2018, 23(2): 85-92. MA Qi, LI Yonghong, YANG Bin, et al. Consensus on the safety of chemotherapy for prostate cancer [J]. Journal of Modern Urology, 2018, 23(2): 85-92.
[9] 林建中, 朱佳庚, 吴宏飞, 等. AXL表达在前列腺癌细胞多西他赛耐药中的作用研究[J]. 中华男科学杂志, 2017, 23(4): 302-308. LIN Jianzhong, ZHU Jiageng, WU Hongfei, et al. Expression of AXL enhances docetaxel-resistance of prostate cancer cells [J]. National Journal of Andrology, 2017, 23(4): 302-308.
[10] Li Y, Yang R, Henzler CM, et al. Diverse AR gene rearrangements mediate resistance to androgen receptor inhibitors in metastatic prostate cancer [J]. Clin Cancer Res, 2020, 26(8): 1965-1976.
[11] 王仕钦, 江春, 黄卫, 等. 普萘洛尔抑制前列腺癌发展的分子机制[J]. 医药导报, 2020, 39(6): 763-769. WANG Shiqin, JIANG Chun, HUANG Wei, et al. Molecular mechanisms of propranolol inhibits the progression of prostate cancer [J]. Herald of Medicine, 2020, 39(6): 763-769.
[12] Spreafico A, Chi KN, Sridhar SS, et al. A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients [J]. Invest New Drugs, 2014, 32(5): 1005-1016.
[13] 范钰, 蒋孟林, 满昌峰, 等. 配对相关同源框-1基因过表达对人胰腺癌细胞侵袭及上皮-间充质转化的影响[J]. 中华实验外科杂志, 2016, 33(7): 1789-1791. FAN Yu, JIANG Menglin, MAN Changfeng, et al. Effects of overexpression of paired-related homeobox 1 gene on invasion and epithelial mesenchymal transition of human pancreatic cancer cells [J]. Chinese Journal of Experimental Surgery, 2016, 33(7): 1789-1791.
[14] Tang Y, Lu Y, Chen Y, et al. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1 [J]. J Exp Clin Cancer Res, 2019, 38(1): 473.
[15] Hirata H, Sugimachi K, Takahashi Y, et al. Downregulation of PRRX1 confers cancer stem cell-like properties and predicts poor prognosis in hepatocellular carcinoma [J]. Ann Surg Oncol, 2015, 22(Suppl 3): 1402-1409.
[16] Nagai MH, Xavier VPS, Gutiyama LM, et al. Depletion of Ric-8B leads to reduced mTORC2 activity [J]. PLoS Genet, 2020, 16(5): 1008255.
[17] Murugan AK. mTOR: role in cancer, metastasis and drug resistance [J]. Semin Cancer Biol, 2019, 59: 92-111. doi: 10.1007/978-3-030-20301-6_15.
[18] Cristofani R, Montagnani MM, Cicardi ME, et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells [J]. Cell Death Dis, 2018, 9(9):889.
[19] Smith AG, Macleod KF. Autophagy, cancer stem cells and drug resistance [J]. J Pathol, 2019, 247(5): 708-718.
[1] GE Li-Juan, JIN Rui-Feng, WANG Ji-Wen, HU Xin-Sheng, LIKun. Association between the C1236T polymorphism in multi-drug resistance gene 1 and response to antiepileptic drug treatment in epileptic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 99-102.
[2] DONG Ping, SHEN Haitao, QIAO Yaqin, LU Yan. Role of autophagy in the regulation of APAP liver injury and liver regeneration process [J]. Journal of Shandong University (Health Sciences), 2026, 64(5): 42-49.
[3] CHEN Yang, FENG Ying, LU Xiao, ZHENG Rong. Galectin-3 promotes autophagy and polarization of macrophages via the PI3K/Akt/mTOR pathway [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 14-22.
[4] LIN Mingxia, LIU Guibin, MA Yanhua, LIAN Zhaoyu, REN Yangyang. ATPase copper transporting alpha mediated cuproptosis pathway and its value in cancer therapy [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 117-124.
[5] ZHANG Qiuping, ZHU Huizhi, LYU Chuan, XIA Yongqi, ZHANG Xiu. Identification of potential key autophagy- and ferroptosis-related genes in asthma based on bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2026, 64(1): 74-87.
[6] LIU Aijing, LI Yanru, GAO Huiru, DUAN Weili, LI Peilong, LI Juan, DU Lutao, WANG Chuanxin. Expression of autophagy-related protein 5 in colon cancer and its impact on the migration and invasion ability of colon cancer cells [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 14-23.
[7] LIU Chao, DIAO Tingting, ZHANG Hongji, LIU Hongwei, YANG Yongrui, LI Xiaofei. Application value of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in the detection of drug resistance of Mycobacterium tuberculosis [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 61-67.
[8] YU Li, WANG Yijia, YANG Yong, LIU Xuehuan, WAN Xuehua, BAO Cuiping, MIAO Beiliang, LI Siqi, LI Jing, LIU Jun. Relationship between fusobacterium nucleatum mediated autophagy and cell refractive index based on optical surface wave [J]. Journal of Shandong University (Health Sciences), 2024, 62(10): 87-97.
[9] XU Yaning, ZHANG Xianglin, LIU Xiaoyu, GUO Haiyang. Construction of endogenous epitope-tagged H1FX cell lines and the chromatin distribution mapping [J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 1-9.
[10] WANG Yanan, LIANG Chuanjie, JIA Mengqi, YUAN Huiqing. Role of protein disulfide isomerase TMX1 in promoting chemotherapy resistance in lung cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 31-39.
[11] ZHENG Ronghui, Li Pan, CAO Xiuqin, HE Ruixia, CHEN Minjia, CHEN Haixia, YANG Zhiwei. SQSTM1 in Legionella pneumophila infected RAW264.7 cells mechanism of autophagy [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 10-21.
[12] REN Huixin, ZHENG Maojin, HAN Wencan, WANG Chaoqun, ZHOU Yun, PEI Dongsheng. Hydrogen peroxide enhances radiotherapy sensitivity of cervical cancer by regulating autophagy [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 22-28.
[13] LIU Na, WANG Nana, JI Bing, DING Xuemei, LIU Yaxin, FANG Xiaoqing, ZHANG Xiaoli. Distribution and drug resistance changes of pathogenic bacteria in hospitalized elderly inpatients from 2012 to 2021 [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 29-40.
[14] JIN Xinjuan, ZUO Liping, DENG Zhanhao, LI Anning, YU Dexin. Value of enhanced MRI radiomics in predicting the drug-resistant protein PFKFB3 in 135 cases of hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 79-86.
[15] HE Jing, YAN Rugen, WU Zhihong, LI Changzhong. Effects of Xiaozheng Yiai decoction on the proliferation and migration of ovarian cancer SKOV3 cells [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 1-10.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd